Ferroportin

From WikiMD's WELLNESSPEDIA

(Redirected from SLC40A1)

Ferroportin is a protein that in humans is encoded by the SLC40A1 gene. It is the only known cellular iron exporter in vertebrates and is essential for the control of body iron homeostasis.

Function[edit]

Ferroportin is a transmembrane protein that functions as an iron transporter. It is expressed on the surface of cells that store or transport iron, such as enterocytes in the duodenum, hepatocytes, and macrophages. Ferroportin allows the transport of iron from the inside of these cells to the outside, where it can be picked up by transferrin and transported to other cells in the body.

Regulation[edit]

The expression and function of ferroportin is regulated by the hormone hepcidin. Hepcidin binds to ferroportin and induces its internalization and degradation, thereby reducing iron export from cells. This mechanism is important for the control of body iron homeostasis and can be disrupted in various diseases, such as hereditary hemochromatosis and anemia of chronic disease.

Clinical significance[edit]

Mutations in the SLC40A1 gene that encodes ferroportin can cause ferroportin disease, also known as type 4 hereditary hemochromatosis. This is a type of iron overload disorder characterized by increased iron absorption from the diet and accumulation of iron in various organs, leading to complications such as liver disease, heart disease, and diabetes.

See also[edit]

References[edit]


External links[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.